Envoy Medical, Inc. - Class A Common Stock, par value $0.0001 per share (COCHW)

Q: What does CUSIP 29415V117 represent in this 13F holders report?

CUSIP 29415V117 is the security identifier for COCHW - Envoy Medical, Inc. - Class A Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held COCHW - Envoy Medical, Inc. - Class A Common Stock, par value $0.0001 per share in Q1 2024?

45 institutional investors reported COCHW - Envoy Medical, Inc. - Class A Common Stock, par value $0.0001 per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 29415V117

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Class A Common Stock, par value $0.0001 per share
Total 13F shares: 7,821,063
Total 13F value: $829,119
Share change: +349,202
SEC-reported price per share: $0.11
Number of holders: 45
Value change: -$262,724
Number of buys: 8
Number of sells: 15
Shares outstanding: 76,914,895

Security key

29415V117

Report period

Q1 2024

Institutions

Top holders

COCHW full security history Ownership snapshot Full 13F holder table Envoy Medical, Inc. SEC filings Envoy Medical, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of COCHW - Envoy Medical, Inc. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Anzu SPAC GP I LLC

Disclosed value leader

Anzu SPAC GP I LLC

Comparable rows

15/15

Latest evidence

31 Dec 2023

13D/G 13F 3/4/5 Lead comparable stake: 11% 13D/G row: Anzu SPAC GP I LLC Showing 1-6 of 15 holder rows.

Quick read

Anzu SPAC GP I LLC leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Anzu SPAC GP I LLC's linked filing trail.

Comparable ownership Top 5

Anzu SPAC GP I LLC 11%

ARISTEIA CAPITAL, L.L.C. 1.4%

Atlas Merchant Capital LLC 1.1%

Diametric Capital, LP 0.69%

Exos TFP Holdings LLC 0.66%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Anzu SPAC GP I LLC	13D/G 13D/G	11%	$3,806,377 2,718,841 shares	$0	29 Sep 2023
ARISTEIA CAPITAL, L.L.C.	13F Company 13F	1.4%	$25,612 1,089,889 shares	—	31 Dec 2023
Atlas Merchant Capital LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	1.1%	$1,674,000 900,000 shares	—	31 Dec 2023
Diametric Capital, LP	13F Company 13F	0.69%	$10,682 534,120 shares	—	31 Dec 2023
Exos TFP Holdings LLC	13F Company 13F	0.66%	$10,201 510,028 shares	—	31 Dec 2023
Man Group plc	13F Company 13F	0.6%	$9,256 462,813 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,821,063

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %